Published in Eur Psychiatry on May 25, 2011
Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study. BMC Psychiatry (2013) 0.81
Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations. Front Psychiatry (2014) 0.79
Predictors of outcome in early-onset psychosis: a systematic review. NPJ Schizophr (2015) 0.78
Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study. PLoS One (2015) 0.78
Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study. Schizophr Bull (2015) 0.78
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial. Trials (2016) 0.78
Comorbid substance use disorders in schizophrenia: a latent class approach. Psychiatry Res (2014) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull (1996) 3.07
Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl (1998) 2.97
Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull (1996) 2.87
Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol (2001) 2.43
The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry (1996) 2.35
Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol (1994) 2.27
Understanding the topography of the early psychosis pathways. An opportunity to reduce delays in treatment. Br J Psychiatry Suppl (1998) 2.25
Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry (1999) 2.14
Behavioural problems in children who weigh 1000 g or less at birth in four countries. Lancet (2001) 2.08
A systematic review of the effectiveness of health service interventions aimed at reducing inequalities in health. J Health Serv Res Policy (1996) 2.08
Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand (1999) 2.06
Age of onset of mental disorders and use of mental health services: needs, opportunities and obstacles. Epidemiol Psychiatr Sci (2012) 2.04
Do you see what I see? Weight status misperception and exposure to obesity among children and adolescents. Int J Obes (Lond) (2008) 1.90
Population history and its impact on medical genetics in Quebec. Clin Genet (2005) 1.85
Sexual initiation: predictors and developmental trends. Sex Transm Dis (2001) 1.85
Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell (1990) 1.80
Homozygous familial hypercholesterolemia among French Canadians in Québec Province. Arteriosclerosis (1989) 1.68
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand (2005) 1.67
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63
[Leishmaniasis and human immunodeficiency virus infections]. Presse Med (1995) 1.61
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr (1998) 1.60
Campylobacter enteritis and erythema nodosum. Lancet (1982) 1.59
A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57
Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res (2001) 1.56
Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol (2002) 1.54
Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res (2012) 1.51
Neurologic crises in hereditary tyrosinemia. N Engl J Med (1990) 1.48
Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr (1995) 1.46
Children of parents with psychotic disorders. Med J Aust (1995) 1.46
Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry (2004) 1.46
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus (2008) 1.45
Metabolic rate, not percent dehydration, predicts rectal temperature in marathon runners. Med Sci Sports Exerc (1991) 1.45
Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics. Psychopathology (2000) 1.44
Comparing correlated kappas by resampling: is one level of agreement significantly different from another? J Psychiatr Res (1997) 1.42
Voluntary screening program for prostate cancer: detection rate and cost. South Med J (1994) 1.42
Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med (2001) 1.41
Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet (1993) 1.40
Is pre-psychotic intervention realistic in schizophrenia and related disorders? Aust N Z J Psychiatry (1997) 1.40
Age and severe mental disorders in homeless and disaffiliated people in inner Melbourne. Med J Aust (1990) 1.38
Medical aspects of ketone body metabolism. Clin Invest Med (1995) 1.37
Does treatment delay in first-episode psychosis really matter? Psychol Med (2003) 1.37
Spatial working memory ability is a marker of risk-for-psychosis. Psychol Med (2003) 1.32
Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J Pediatr (1999) 1.31
Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry (2000) 1.29
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation (2002) 1.29
Perioperative anaphylaxis. Med Clin North Am (2010) 1.29
Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) (2003) 1.27
Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry (2006) 1.24
Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr Res (2006) 1.24
Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry (2008) 1.24
Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nat Genet (1999) 1.21
Isolation of Campylobacter hyointestinalis from pigs in the United Kingdom. Vet Rec (1984) 1.21
Mycoplasma pneumoniae infections in a rural setting in Canada. CMAJ (1987) 1.20
Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev (2010) 1.19
Physical activity vs. sedentary time: independent associations with adiposity in children. Pediatr Obes (2012) 1.19
Genomic, protein homogeneity and antigenic variability of Mycoplasma agalactiae. Vet Microbiol (1996) 1.19
Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry (2007) 1.18
Deletion proximal to DXS68 locus (L1 probe site) in a boy with Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal hypoplasia. Hum Genet (1988) 1.18
A disturbed sense of self in the psychosis prodrome: linking phenomenology and neurobiology. Neurosci Biobehav Rev (2009) 1.16
Administration of medicines by emergency nurse practitioners according to protocols in an accident and emergency department. J Accid Emerg Med (1997) 1.15
Pre-existing arterial stiffness can predict hypotension during induction of anaesthesia in the elderly. Br J Anaesth (2010) 1.15
Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand (2010) 1.14
Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo. Biotechnology (N Y) (1991) 1.13
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand (2005) 1.13
A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res (2001) 1.12
Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol (2002) 1.12
On the HORYZON: moderated online social therapy for long-term recovery in first episode psychosis. Schizophr Res (2012) 1.11
Ambient pH signalling in ascomycetous yeasts involves homologues of the Aspergillus nidulans genes palF and paIH. Mol Gen Genet (2000) 1.11
Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand (2006) 1.11
Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry (2001) 1.11
Visuospatial memory and learning in first-episode schizophreniform psychosis and established schizophrenia: a functional correlate of hippocampal pathology? Psychol Med (2002) 1.10
Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res (2003) 1.10
Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem (1997) 1.09
Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry (2011) 1.09
Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol (2001) 1.08
Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res (2010) 1.08
Mediterranean spotted fever in Belgium. Lancet (1984) 1.06
Elevated serum heat-shock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assay. Scand J Immunol (2003) 1.06
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. N Engl J Med (1991) 1.06
The Second National Mental Health Plan: an opportunity to take stock and move forward. Med J Aust (1998) 1.05
Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res (2006) 1.05
Copper transport. Am J Clin Nutr (1998) 1.04
Evaluation of the National Acoustic Laboratories' new hearing aid selection procedure. J Speech Hear Res (1988) 1.04
Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project. Psychol Med (2007) 1.03
Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient. J Clin Invest (1992) 1.02
Reduced brain choline in homocystinuria due to remethylation defects. Neurology (2008) 1.02
Preventing severe mental illnesses--new prospects and ethical challenges. Schizophr Res (2001) 1.01
Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. Acta Psychiatr Scand (2014) 1.01
Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. J Clin Invest (1991) 1.01
Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatr Scand (2006) 1.00
Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res (2009) 1.00